GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the release to ...

Inogen, Inc. INGN has been gaining on the back of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a strong product portfolio ...

Inogen, Inc. INGN is gaining on its solid product portfolio expansion and strong momentum within European markets. However, forex headwinds have been offsetting the positives to some extent. The ...

Inogen Inc. research and ratings by Barron's. View INGN revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Good afternoon and welcome to the Inogen 2018 Fourth Quarter Financial Results Conference Call and Webcast. All participants will be in listen-only mode. [Operator Instructions] Please note, this ...

Welcome to Inogen’s Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session.